Measured Wealth Private Client Group LLC Has $340,000 Holdings in The Procter & Gamble Company (NYSE:PG)

Measured Wealth Private Client Group LLC cut its position in The Procter & Gamble Company (NYSE:PG) by 6.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 1,963 shares of the company’s stock after selling 140 shares during the quarter. Measured Wealth Private Client Group LLC’s holdings in Procter & Gamble were worth $340,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $29,000. Ruedi Wealth Management Inc. grew its position in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares during the period. POM Investment Strategies LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $34,000. Finally, Quest Partners LLC acquired a new position in Procter & Gamble during the second quarter valued at approximately $36,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Procter & Gamble

In related news, insider Susan Street Whaley sold 450 shares of the stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the sale, the insider now owns 13,072 shares in the company, valued at approximately $2,212,043.84. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, insider Susan Street Whaley sold 450 shares of the stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 389,144 shares of company stock valued at $66,184,385 in the last ninety days. Corporate insiders own 0.18% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on PG. Deutsche Bank Aktiengesellschaft upped their price target on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. TD Cowen began coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. Piper Sandler initiated coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target on the stock. Finally, Morgan Stanley increased their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Price Performance

PG opened at $165.88 on Thursday. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94. The stock has a 50-day moving average price of $171.80 and a 200-day moving average price of $167.86. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a market cap of $390.65 billion, a PE ratio of 28.67, a P/E/G ratio of 3.64 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.83 EPS. Sell-side analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.43%. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.